Case Studies
Please scroll to see what we have done so far. Feel free to contact us to know more.
Gun-Death Case Study using data from Center for Disease Control (CDC)
We explored gun related deaths in US from 2014 to 2016 to obtain some valuable insights regarding the worthiness of Gun Control law. The data primarily came from the Centers for Disease Control and Prevention's Multiple Cause of Death database. This is derived from death certificates from all 50 states and the DC. It is considered one of the most inclusive appraisal of firearm deaths.
Start-up Feasibility Analysis
Start-up feasibility analysis for a scientifically-based horticultural and environmental service company in Maryland was performed for our client. Client was advised whether to go for such an start-up after an exhaustive analysis based on several factors like growth rate of the market, competitive response, supply & demand issues, affordability of debt in current economic condition, margins required for minimum sustenance, major barriers to entry (customer loyalty and market dominance by couple of major players) and major barriers to exit (non-transferable fixed assets and contract requirements with the suppliers)
Entering a New Market Case
Entering a New Market Case for an aspiring entrepreneur once marijuana becomes legal in Maryland like DC. Client was advised if he should go for such an start-up after a sweeping analysis of several factors like market size, customer segmentation, competition, distribution channels, major barriers to entry and major barriers to exit.
Pricing Strategy
Requested by a hotel executive to develop pricing strategy for his hotel. Collected hotel’s historic daily occupancy and average pricing data. Visualized occupancy trend and seasonality. Modeled occupancy based on various attributes like view, access to hotel club, floor, free mini bar, guest smart phone, cancellation etc. Obtained surprising results that some factors were more important than others. Helped the owner of the hotel to make analytically informed pricing strategy instead of a gut based one.
